poisar

Stocks · News reference

CORRECTION: iRadimed Raises FY2026 Adj EPS Guidance from $2.06-$2.21 to $2.09-$2.24 vs $2.08 Est; Affirms FY2026 Sales Guidance of $91.000M-$96.000M vs $91.300M Est

BenzingaBenzinga News-desk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K/A filing — IRADIMED CORP (IRMD)

    Filed: 2026-08-18 AccNo: 0001628280-26-057617 Size: 337 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits